Loading...

OVID OVID THERAPEUTICS INC Investments/Divestments 8-K Filing

VD T

VD

OVID THERAPEUTICS INC

(OVID)

2023 8-K

Show Summary

Show Summary

Asset Acquisitions

Financial Results

Board Appointment

Q3 2024 Results

Management Change

Q2 2024 Results

Departure of Directors

Annual Meeting Results

Earnings Reports

Financial Results

Earnings Reports

Earnings Reports

Annual Meeting Results

Earnings Reports

Collaboration and License A...

Financial Results Announcement

Regulation FD Disclosure

External Links:

Ovid Therapeutics announces Long-Term Safety & Efficacy Finding from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology.

AI Assistant

OVID THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.